Team Supported by Generous Grants from the Cless Family Foundation and Sara & Jeff Schottenstein Family Charitable Fund SANTA...
PHILADELPHIA — The targeted therapy combination of the mTOR inhibitor everolimus (Afinitor) and the somatostatin agonist octreotide (Sandostatin) yielded...
PHILADELPHIA — Adolescent and young adults who survived at least two years after a cancer diagnosis had nearly double...
Study reports the landscape of mutations present in pediatric acute lymphoblastic leukemia (ALL) and how this landscape changes during...
PHILADELPHIA —American cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending,...
PHILADELPHIA — Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemoradiotherapy was associated with poor response and increased risk...
PHILADELPHIA, PA and CAMBRIDGE, MA – Two grants for research that could transform cancer therapies have been funded through...
The American Association for Cancer Research and the St. Baldrick’s Foundation are pleased to announce the creation of the AACR-St....
Study also indicated that a lack of ctDNA may signal improved outcomes for patients SAN ANTONIO — The presence...
SAN ANTONIO — A large meta-analysis of breast cancer patients showed that residual cancer burden after neoadjuvant chemotherapy is...